Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
GWQ SERVICEPLUS AG has floated a tender for Conclusion of a Non-exclusive Discount Agreement According to Section 130a (8) Sgb V for the Active Ingredient Adalimumab. The project location is Germany and the tender is closing on 10 Nov 2022. The tender notice number is 566329-2020, while the TOT Ref Number is 47871057. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Germany
Summary : Conclusion of a Non-exclusive Discount Agreement According to Section 130a (8) Sgb V for the Active Ingredient Adalimumab
Deadline : 10 Nov 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 47871057
Document Ref. No. : 566329-2020
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : EUR 1.00
Purchaser's Detail
Purchaser : GWQ SERVICEPLUS AG
Address: acting for the statutory health insurance companies mentioned in detail under VI 2.)
Town: Düsseldorf
NUTS code: DE - GERMANY
Postal Code: 40474
Phone: +49 211758498-0
Fax: +49 211758498-48
Germany
Email :bieteranfrage@gwq-serviceplus.de
URL :http://www.gwq-serviceplus.de
Tender Details
Document Type: Contract notice
Title: Conclusion of a non-exclusive discount agreement according to Section 130a (8) SGB V for the active ingredient Adalimumab
Reference Number: 2020 / S 230-566329
Contract Type: Supplies
Estimated Value: 1.00 - EUR
Description: Section 130a, Paragraph 8 of Book V of the Social Code enables the health insurances (KK) and pharmaceutical companies to conclude framework discount agreements for drugs to be dispensed at the expense of the statutory KK. The GWQ is a company for efficiency and quality at KK acc. According to Section 130a, Paragraph 8, Sentence 5, SGBV, they work for their shareholder and customer accounts. With regard to the relevant legal regulations for the award of public contracts, a regular process of active substance-related, formal award procedures according to the regulations of the 4th part of the GWB takes place by GWQ ServicePlus AG. Until new drug discount agreements come into force, GWQ would like to conclude drug discount agreements with all interested pharmaceutical companies as part of the open-house procedure for preparations with the active ingredient adalimumab. The earliest contract start is January 1, 2021.
33600000 - Pharmaceutical products ...
Documents
Want To Bid in This Tender?
Get Local Agent Support in Germany and 60 More Countries.
View Tenders By
Sign in with Google